Deals
Deals dated after 30 September 2026 are still being collected.
Columns
1 of 1 deals
| Advisers | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 2026 | Cumberland FDA-approved commercial products and related assets | Cumberland Pharmaceuticals | Nuvo Pharmaceuticals (Ireland) DAC | Asset sale | Financial adviser to Cumberland Pharmaceuticals (seller); Fairness opinion to Cumberland Board (target) | Pending | 100.0 | Pharma | Baker Donelson (sell-side)Kirkland & Ellis (buy-side) | Nuvo Pharmaceuticals (Ireland) DAC acquisition of Cumberland FDA-approved commercial products and related assets |